However, fetal tumor and embryonal tumor organoids exhibited differential sensitivity to receptor tyrosine kinase inhibitors: embryonal organoids were sensitive to FGFR inhibitors, but fetal organoids responded to EGFR inhibitors. Here, EGFR is linked to neoplasm.